{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:03:30Z","timestamp":1754111010504},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch. Pharmacol."],"published-print":{"date-parts":[[1984]]},"DOI":"10.1007\/bf00504996","type":"journal-article","created":{"date-parts":[[2004,11,17]],"date-time":"2004-11-17T14:34:07Z","timestamp":1100702047000},"page":"81-85","source":"Crossref","is-referenced-by-count":7,"title":["Plasma protein binding and interaction studies with piroxicam"],"prefix":"10.1007","volume":"327","author":[{"given":"Zdena","family":"Trnavsk\ufffd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Trnavsk\ufffd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.2042-7158.1979.tb13509.x","volume":"31","author":"LI Aarons","year":"1979","unstructured":"Aarons LI, Schary WL, Rowland M (1979) A in vitro study of drug displacement interactions: warfarin-salicylate and warfarin-phenylbutazone J Pharm Pharmacol 31:322?330","journal-title":"J Pharm Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0006-2952(78)90513-0","volume":"27","author":"SK Chakrabarti","year":"1978","unstructured":"Chakrabarti SK (1978) Cooperativity of warfarin binding with human serum albumin induced by free fatty anion. Biochem Pharmacol 27:739?743","journal-title":"Biochem Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00003495-198325050-00003","volume":"25","author":"JC McElnay","year":"1983","unstructured":"McElnay JC, D'Arcy PF (1983) Protein binding displacement interactions and their clinical importance. Drugs 25:495?513","journal-title":"Drugs"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0006-2952(81)90149-0","volume":"30","author":"KJ Fehske","year":"1981","unstructured":"Fehske KJ, M\u00fcller WE, Wollert U (1981) The localization of drug binding sites in human serum albumin. Biochem Pharmacol 30:678?692","journal-title":"Biochem Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1021\/ja01548a024","volume":"80","author":"DS Goodman","year":"1958","unstructured":"Goodman DS (1958) The interaction of human serum albumin with long-chain fatty acid anions. J Am Chem Soc 80:3892?3898","journal-title":"J Am Chem Soc"},{"key":"CR6","first-page":"46","volume":"6","author":"DC Hobbs","year":"1983","unstructured":"Hobbs DC (1983) Pharmacokinetics of piroxicam in man. Eur J Rheum Inflam 6:46?55","journal-title":"Eur J Rheum Inflam"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/j.1552-4604.1979.tb02480.x","volume":"19","author":"DC Hobbs","year":"1979","unstructured":"Hobbs DC, Twomey TM (1979) Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. J Clin Pharmacol 19:270?281","journal-title":"J Clin Pharmacol"},{"key":"CR8","first-page":"259","volume":"12","author":"D Hultmark","year":"1975","unstructured":"Hultmark D, Borg KO, Elofsson R, Palmer L (1975) Interaction between salicylic acid and indomethacin in binding to human serum albumin. Acta Pharm Suec 12:259?276","journal-title":"Acta Pharm Suec"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01062535","volume":"7","author":"T Ishizaki","year":"1979","unstructured":"Ishizaki T, Nomura T, Abe T (1979) Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man. J Pharmacokin Biopharmacol 7:369?381","journal-title":"J Pharmacokin Biopharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0014-5793(69)80307-8","volume":"5","author":"J Jacobsen","year":"1969","unstructured":"Jacobsen J (1969) Binding of bilirubin to human serum albumin. ?Determination of the dissociation constants. Fed Eur Biochem Soc Lett 5:112?114","journal-title":"Fed Eur Biochem Soc Lett"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0003-9861(79)90036-5","volume":"193","author":"IM Klotz","year":"1979","unstructured":"Klotz IM, Hunston DL (1979) Protein affinities for small molecules: Conceptions and misconceptions. Arch Biochem Biophys 193:314?328","journal-title":"Arch Biochem Biophys"},{"key":"CR12","first-page":"17","volume":"33","author":"U Krach-Hansen","year":"1981","unstructured":"Krach-Hansen U (1981) Molecular aspects of ligand binding to serum albumin. Pharmacol Rewievs 33:17?53","journal-title":"Pharmacol Rewievs"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03602537909046431","volume":"9","author":"G Levy","year":"1979","unstructured":"Levy G (1979) Pharmacokinetics of salicylate in man. Drug Metabolism Rewievs 9:3?19","journal-title":"Drug Metabolism Rewievs"},{"key":"CR14","volume-title":"A user manual for NONLIN and associated programs","author":"CM Metzler","year":"1974","unstructured":"Metzler CM, Elfring GL, McEwen AJ (1974) A user manual for NONLIN and associated programs. The Upjohn Co., Kalamazoo"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-2275(20)39315-9","volume":"6","author":"M Nov\u00e1k","year":"1965","unstructured":"Nov\u00e1k M (1965) Colorimetric ultramicro method for the determination of free fatty acids. J Lipid Res 6:431?433","journal-title":"J Lipid Res"},{"key":"CR16","first-page":"215","volume":"31","author":"S Rendi?","year":"1981","unstructured":"Rendi? S, Alebi?-Kolbah T, Kajfe? F (1981) Binding of piroxicam to human serum albumin. Acta Pharm Jugoslavica 31:215?220","journal-title":"Acta Pharm Jugoslavica"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5173(82)90173-9","volume":"11","author":"MJ Ridd","year":"1982","unstructured":"Ridd MJ, Brown KF, Moore RG, Nation RL (1982) Drug plasma binding and non-esterified fatty acids: methodologic considerations. Internat J Pharmaceutics 11:11?20","journal-title":"Internat J Pharmaceutics"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0003-2697(67)90297-7","volume":"20","author":"HE Rosenthal","year":"1967","unstructured":"Rosenthal HE (1967) A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem 20:525?532","journal-title":"Anal Biochem"},{"key":"CR19","first-page":"261","volume":"176","author":"D Rudman","year":"1971","unstructured":"Rudman D, Bixler TJ, Del Rio AE (1971) Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabit serum. J Pharmacol Exp Therap 176:261?272","journal-title":"J Pharmacol Exp Therap"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","volume":"51","author":"G Scatchard","year":"1949","unstructured":"Scatchard G (1949) The attraction of protein for small molecules and ions. Ann NY Acad Sci 51:660?672","journal-title":"Ann NY Acad Sci"},{"key":"CR21","first-page":"92","volume":"31","author":"P Schiantarelli","year":"1981","unstructured":"Schiantarelli P, Acerbi D, Bovis G (1981) Some pharmacokinetics properties and bioavailability by oral and rectal route of piroxicam in rodent and in man. Arzneim Forsch drug Res 31:92?97","journal-title":"Arzneim Forsch drug Res"},{"key":"CR22","first-page":"767","volume":"16","author":"I Sj\u00f6holm","year":"1979","unstructured":"Sj\u00f6holm I, Ekman B, Kober A, Ljungstedt-P\u00e4hlman I, Seiving B, Sj\u00f6din T (1979) Binding of drugs to human serum albumin: XI Mol Pharmacol 16:767?777","journal-title":"Mol Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-2952(68)90166-4","volume":"17","author":"HM Solomon","year":"1968","unstructured":"Solomon HM; Schrogie JJ, Williams D (1968) The displacement of phenylbutazone-14C and warfarin-1\/2 \u00f7C from human albumin by various drugs and fatty acids. Biochem Pharmacol 17:143?151","journal-title":"Biochem Pharmacol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00560349","volume":"7","author":"JP Tillement","year":"1974","unstructured":"Tillement JP, Zini R, D'Athis P, Vassent G (1974) Binding of certain acidic drugs to human albumin: Theoretical and practical estimation of fundamental parameters. Eur J Clin Pharmacol 7:307?313","journal-title":"Eur J Clin Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2165\/00003088-197803020-00004","volume":"3","author":"JP Tillement","year":"1978","unstructured":"Tillement JP, Lhoste F, Giudicelli JF (1978) Diseases and drug protein binding. Clin Pharmacokin 3:144?154","journal-title":"Clin Pharmacokin"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0006-2952(75)90355-X","volume":"24","author":"E Tsutsumi","year":"1974","unstructured":"Tsutsumi E, Inaba T, Mahon WA, Kalow W (1974) The displacing effect of a fatty acid on the binding of diazepam to human serum albumin. Biochem Pharmacol 24:1361?1362","journal-title":"Biochem Pharmacol"},{"key":"CR27","first-page":"244","volume-title":"Fluorescence assay in biology and medicine","author":"S Udenfried","year":"1962","unstructured":"Udenfried S (1962) Fluorescence assay in biology and medicine. Academic Press, New York London p 244"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1552-4604.1975.tb01470.x","volume":"15","author":"ES Vesel","year":"1975","unstructured":"Vesel ES, Passanati T, Johnson AO (1975) Failure of indomethacin and warfarin to interact in normal human volunteers. J Clin Pharmacol 15:486?495","journal-title":"J Clin Pharmacol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/03602538308991396","volume":"14","author":"GR Wilkinson","year":"1983","unstructured":"Wilkinson GR (1983) Plasma and tissue binding considerations in drug disposition. Drug metabolism rewievs 14:427?465","journal-title":"Drug metabolism rewievs"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0005-2795(80)90123-3","volume":"626","author":"J Wilting","year":"1980","unstructured":"Wilting J, Thart BJ, De Gier JJ (1980) The role of albumin conformation in the binding of diazepam to human serum albumin. Biochim Biophys Acta 626:291?298","journal-title":"Biochim Biophys Acta"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00504996.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00504996\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00504996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T21:39:49Z","timestamp":1624916389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00504996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984]]}},"alternative-id":["BF00504996"],"URL":"https:\/\/doi.org\/10.1007\/bf00504996","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984]]}}}